Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL104205 | 1.00 | THRB (0.46) | THRBALDH1A1TSHR | |
| SCHEMBL504018 | 0.88 | THRB (0.55) | THRBALDH1A1TSHR | |
| SCHEMBL8968 | 0.88 | — | — | |
| SCHEMBL27028519 | 0.88 | THRB (0.55) | THRBALDH1A1TSHR | |
| SCHEMBL16291745 | 0.84 | THRB (0.54) | THRBALDH1A1TSHR | |
| SCHEMBL789340 | 0.82 | — | — | |
| SCHEMBL129302 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL8694521 | 0.82 | — | — | |
| SCHEMBL21494164 | 0.82 | THRB (0.50) | THRBALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL7537660 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117940133-A | Therapeutic agents for degradation of mutant BRAF | C4医药公司 | 2024-04-26 | — | — | CN | disclosed |
| EP-3368520-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-04-26 | — | — | EP | disclosed |
| CN-110256418-B | 1, 3-thiazol-2-yl substituted benzamides | 拜耳公司 | 2023-01-20 | — | — | CN | disclosed |
| CN-113135828-B | Aromatic amine, alpha-diimine ligand and nickel catalyst based on rigid terphenyl structure and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2022-11-22 | — | — | CN | disclosed |
| CN-115335373-A | Compound and use thereof | 福宏治疗公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-110325537-B | Anthracene derivative and organic light emitting device including the same | 株式会社LG化学 | 2022-10-28 | — | — | CN | disclosed |
| CN-115232024-A | Aromatic amine containing azobenzene based on terphenyl structure, alpha-diimine ligand, nickel catalyst and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2022-10-25 | — | — | CN | disclosed |
| CN-115135653-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2022-09-30 | — | — | CN | disclosed |
| CN-115135652-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2022-09-30 | — | — | CN | disclosed |
| CN-114787173-A | Metal complexes | 默克专利有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-107207507-B | 1, 3-thiazol-2-yl substituted benzamides | 拜耳公司 | 2020-11-06 | — | — | CN | disclosed |
| WO-2020041743-A1 | WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-02-27 | — | — | WO | disclosed |
| CN-110540538-A | Inhibitors of influenza virus replication | VERTEX PHARMA | 2019-12-06 | — | — | CN | disclosed |
| US-20190058133-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-02-21 | — | — | US | disclosed |
| EP-3368520-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2018-09-05 | — | — | EP | disclosed |
| WO-2017133667-A1 | PYRIMIDINE AND PYRIDINE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017071791-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-05-04 | — | — | WO | disclosed |
| EP-1768988-B1 | NOVEL PHENYL-BORONIC ACID DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF | GALDERMA RES & DEV (FR) | 2009-01-28 | — | — | EP | disclosed |
| EP-1768988-A1 | NOVEL PHENYL-BORONIC ACID DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF | Galderma Research & Development, S.N.C. (FR) | 2007-04-04 | — | — | EP | disclosed |
| WO-2005061520-A1 | NOVEL PHENYL-BORONIC ACID DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2005-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190058133-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SLCO4C1, SLCO2A1, SLCO2B1 | THRB 3737/4885ALDH1A1 1315/4885TSHR 4479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.